Omnicell (OMCL) stock jumps as KeyBanc Capital Markets upgrades the firm, citing a "super-cycle" of growth driven by its new ...

Pyxis secured S$13 million in the first close of its S$18 million growth funding round, reflecting strong investor confidence in its vessel technology, commercial traction, and regional growth ...

Q4 revenue of $5.9 billion increased 8.3% as reported, 7.0% FXN and 3.9% organic Q4 GAAP and adjusted diluted EPS grew to $1.72 and $3.96, respectively FY25 revenue of $21.8 billion increased 8.2% as ...

Earnings call BD reported Q4 revenue of $5.9B (+7% YoY, +3.9% organic) and record FY25 revenue of $21.8B (+7.7% YoY, +2.9% organic). Adjusted EPS grew 9.6% to $14.40 despite a 2-point tariff headwind.

(MENAFN- ProGlobal Media) RIYADH, Kingdom of Saudi Arabia (27 October 2025) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today marked its third ...

Becton, Dickinson and Company BDX, popularly known as BD, recently launched its new AI-enabled BD Incada Connected Care Platform alongside the next-generation BD Pyxis Pro Automated Medication ...

FRANKLIN LAKES, N.J. - Medical technology company BD (NYSE:BDX), a $54.2 billion healthcare equipment leader with robust annual revenue of $21.39 billion and steady 7.86% growth, announced on Monday ...